Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| TNET | TRINET GROUP INC | United States | $5.25B | 50,563,849 | 68.69% | 31.31% | Net Selling | Net Selling |
| NGNE | NEUROGENE INC | United States | $432.37M | 12,980,289 | 43.00% | 57.00% | Net Buying | |
| EYPT | EYEPOINT PHARMACEUTICALS INC | United States | $616.68M | 52,084,375 | 21.75% | 78.25% | Net Selling | Net Buying |
| CPA | COPA HOLDINGS SA | Panama | $4.60B | 42,039,814 | 63.99% | 0.00% | ||
| DAWN | DAY ONE BIOPHARMACEUTICALS INC | United States | $1.41B | 87,389,859 | 53.37% | 46.63% | Net Buying | Net Selling |
| GEF | GREIF INC | United States | $3.01B | 47,121,156 | 51.02% | 48.84% | Net Selling | Net Selling |
| APTO | APTOSE BIOSCIENCES INC | Canada | $19.25M | 16,309,393 | 6.21% | 65.32% | Net Buying | |
| ANNX | ANNEXON INC | United States | $400.15M | 92,412,866 | 79.11% | 20.89% | Net Buying | Net Selling |
| ACLS | AXCELIS TECHNOLOGIES INC | United States | $3.68B | 32,532,498 | 91.25% | 8.30% | Net Selling | Net Selling |
| DNTH | DIANTHUS THERAPEUTICS INC | United States | $752.23M | 29,349,469 | 45.65% | 54.35% | Net Buying | |
| APGE | APOGEE THERAPEUTICS INC | United States | $2.94B | 58,456,027 | 89.97% | 10.03% | Net Buying | |
| SNDX | SYNDAX PHARMACEUTICALS INC | United States | $1.72B | 84,987,060 | 91.49% | 8.51% | Net Buying | |
| RRX | REGAL REXNORD CORP | United States | $10.62B | 66,518,762 | 97.50% | 2.41% | Net Selling | Net Selling |
| IMVT | IMMUNOVANT INC | United States | $4.46B | 145,292,970 | 45.31% | 54.69% | Net Buying | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.